<div dir="ltr"><div class="gmail_quote"><br><div class="msg7397821973951513267"><div lang="EN-US" link="blue" vlink="#954F72" style="word-wrap:break-word"><div class="m_7397821973951513267WordSection1"><div><div><p class="MsoNormal" style="background:white;vertical-align:baseline"><b><span style="font-size:12.0pt;font-family:"Aptos",sans-serif;color:black">CALL FOR PAPERS  - Deadline is November 17</span></b><span style="font-size:12.0pt;font-family:"Aptos",sans-serif;color:black"><u></u><u></u></span></p></div><p class="MsoNormal" style="background:white;vertical-align:baseline"><span style="font-size:12.0pt;font-family:"Aptos",sans-serif;color:black"><u></u> </span></p><div><p style="margin:0in;background:white"><b><span style="font-size:14.0pt;font-family:"inherit",serif;color:black;border:none windowtext 1.0pt;padding:0in">Evidence-Based Medicine Reconsidered<u></u><u></u></span></b></p><p style="margin:0in;background:white"><br></p></div><p style="margin-right:0in;margin-bottom:9.0pt;margin-left:0in;background:white"><b><span style="font-size:12.0pt;font-family:"Aptos",sans-serif;color:black">Conference Dates: April 5-6th, 2025<u></u><u></u></span></b></p><p style="margin-right:0in;margin-bottom:9.0pt;margin-left:0in;background:white"><span style="font-size:12.0pt;font-family:"Aptos",sans-serif;color:black">University of Pittsburgh, Pittsburgh, PA</span></p><div style="margin-bottom:9.0pt;font-variant-ligatures:normal;font-variant-caps:normal;font-variant-numeric:inherit;font-variant-east-asian:inherit;font-variant-alternates:inherit;font-stretch:inherit;font-size-adjust:inherit;font-kerning:inherit;font-feature-settings:inherit;text-decoration-style:initial;text-decoration-color:initial;word-spacing:0px"><p class="MsoNormal" style="background:white;vertical-align:baseline"><span style="font-size:12.0pt;font-family:"Aptos",sans-serif;color:black">Senior Visiting Fellow Conference by Carl Hoefer</span></p></div><p class="MsoNormal" style="background:white;vertical-align:baseline"><span style="font-size:12.0pt;font-family:"Aptos",sans-serif;color:black">The evidence-based medicine (EBM) movement began in the 1980s, reached its peak perhaps in the 1990s, and has since then enjoyed the status of orthodoxy, despite many criticisms being raised among medical practitioners and researchers. Philosophers of medicine have frequently criticized EBM’s hierarchies and rigid precepts, especially the “gold standard” status of randomized controlled trials (RCTs). A pluralistic approach to evidence in medicine has been increasingly popular in recent years, in which mechanistic evidence and reasoning, observational studies of many kinds and RCTs are assessed for value on a case-by-case basis. But does this trend away from the EBM hierarchy go too far and risk the reintroduction of the same biased, motivated evidence-gathering practices that originally motivated the EBM movement? What light can recent experiences in medicine and public health (e.g., during the covid-19 pandemic) shed on these issues?<u></u><u></u></span></p><p class="MsoNormal" style="background:white;vertical-align:baseline"><span style="font-size:12.0pt;font-family:"Aptos",sans-serif;color:black"> <u></u><u></u></span></p><p class="MsoNormal" style="background:white;vertical-align:baseline"><span style="font-size:12.0pt;font-family:"Aptos",sans-serif;color:black">Visit the website for the most up-to- date information and registration:  <a href="https://www.centerphilsci.pitt.edu/event/evidence-based-medicine-reconsidered/" target="_blank">https://www.centerphilsci.pitt.edu/event/evidence-based-medicine-reconsidered/</a></span><span style="font-size:12.0pt;font-family:"Aptos",sans-serif;color:black"><u></u><u></u></span></p><div style="margin-top:12.0pt;margin-bottom:9.0pt;font-variant-ligatures:normal;font-variant-caps:normal;font-variant-numeric:inherit;font-variant-east-asian:inherit;font-variant-alternates:inherit;font-stretch:inherit;font-size-adjust:inherit;font-kerning:inherit;font-feature-settings:inherit;text-decoration-style:initial;text-decoration-color:initial;word-spacing:0px"><p class="MsoNormal" style="background:white;vertical-align:baseline"><b><span style="font-size:12.0pt;font-family:"Aptos",sans-serif;color:black"><u></u> <u></u></span></b></p><p class="MsoNormal" style="background:white;vertical-align:baseline"><b><span style="font-size:12.0pt;font-family:"Aptos",sans-serif;color:black">Call for Abstracts</span></b><span style="font-size:12.0pt;font-family:"Aptos",sans-serif;color:black"><u></u><u></u></span></p></div><p class="MsoNormal" style="background:white;vertical-align:baseline"><span style="font-size:12.0pt;font-family:"Aptos",sans-serif;color:black">We invite papers which address topics related to evidence in medicine, broadly speaking. These include, but are not limited to:<u></u><u></u></span></p><ul style="margin-top:0in" type="disc"><li class="MsoNormal" style="color:black;background:white"><span style="font-size:12.0pt;font-family:"Aptos",sans-serif">Defenses (or criticisms) of the supposed superiority of RCTs over observational studies, mechanistic studies, modeling, and individual clinical judgment;<u></u><u></u></span></li><li class="MsoNormal" style="color:black;margin-top:6.0pt;background:white"><span style="font-size:12.0pt;font-family:"Aptos",sans-serif">Discussions of lessons that philosophy of medicine or EBM can learn from recent experiences;<u></u><u></u></span></li><li class="MsoNormal" style="color:black;margin-top:6.0pt;background:white"><span style="font-size:12.0pt;font-family:"Aptos",sans-serif">Papers offering theoretical discussions of procedures for integrating and evaluating evidence from different sources;<u></u><u></u></span></li><li class="MsoNormal" style="color:black;margin-top:6.0pt;background:white"><span style="font-size:12.0pt;font-family:"Aptos",sans-serif">The merits and limitations of emerging kinds of medical evidence, such as adaptive trials, so-called real-world evidence, precision or personalized medicine research, and big data research<u></u><u></u></span></li><li class="MsoNormal" style="color:black;margin-top:6.0pt;background:white"><span style="font-size:12.0pt;font-family:"Aptos",sans-serif">Evidence in diverse contexts, such as clinical practice, alternative healthcare, drug or device regulation, public health, and health policy.<u></u><u></u></span></li></ul><p class="MsoNormal" style="background:white;vertical-align:baseline"><b><span style="font-size:12.0pt;font-family:"inherit",serif;color:black;border:none windowtext 1.0pt;padding:0in"><u></u> <u></u></span></b></p><p class="MsoNormal" style="background:white;vertical-align:baseline"><b><span style="font-size:12.0pt;font-family:"inherit",serif;color:black;border:none windowtext 1.0pt;padding:0in">Abstracts should be between 500-800 words long and should be sent by November 17th to:</span></b><span style="font-size:12.0pt;font-family:"Aptos",sans-serif;color:black"> </span><span style="color:black"><a href="mailto:SVFC.2025@gmail.com" target="_blank"><span style="font-size:12.0pt;font-family:"Aptos",sans-serif;border:none windowtext 1.0pt;padding:0in">SVFC.2025@gmail.com</span></a></span><span style="font-size:12.0pt;font-family:"Aptos",sans-serif;color:black"><u></u><u></u></span></p></div><p class="MsoNormal"><u></u> <u></u></p></div></div>
</div></div></div>